Design Therapeutics Q1 EPS $(0.31) Misses $(0.28) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings MissesNews
Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.28) by 10.71 percent. This is a 55 percent decrease over losses of $(0.20) per share
Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.28) by 10.71 percent. This is a 55 percent decrease over losses of $(0.20) per share from the same period last year.